3) Guidance on Barocycler Sales: on August 14th, the Company announced that it expected to install at least fourteen (14) PCT Sample Preparation Systems during Q32008. The Company is pleased to announce that it has installed 17 PCT Systems, as compared to 7 in the second quarter of 2008. Furthermore, the Company expects to meet or exceed its previously announced full year guidance of 40 installations.
Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc., commented: "The continued publications and presentations from early adopters of PCT is helping us tremendously in our commercialization efforts. We attribute a significant portion of our recent commercial success to testimonials like the ones highlighted above, that herald the merits of pressure cycling technology in various applications of life sciences, as well as the advantages of PCT over other sample preparation methods available today. We would like to congratulate our customers and collaborators for their important research studies and for their continued support of PCT."
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused
on the development and commercialization of a novel, enabling technology
called pressure cycling technology (PCT). PCT uses cycles of hydrostatic
pressure between ambient and ultra-high levels (up to 35,000 psi and
greater) to control bio-molecular interactions. PBI currently holds 13 US
and 6 foreign patents covering multiple applications of PCT in the life
sciences field, including in such areas as genomic and proteomic sample
preparation, pathogen inactivati
|SOURCE Pressure BioSciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved